Literature DB >> 23947076

Comparison of operative risks associated with radical hysterectomy in pregnant and nonpregnant women.

Charles A Leath1, Kerri S Bevis, T Michael Numnum, Patrick S Ramsey, Warner K Huh, J Michael Straughn.   

Abstract

OBJECTIVE: To compare the operative data and complications of radical hysterectomy performed on pregnant women versus nonpregnant women. STUDY
DESIGN: Following institutional review board approval, we reviewed our surgical databases to identify pregnant women who had undergone a radical hysterectomy for cervical carcinoma from 1992-2005 (n = 7). A nonpregnant control group (n = 35) of women undergoing radical hysterectomy during the study interval were identified and matched for age, year of surgery, and surgeon. Pertinent operative and outcome data were abstracted and compared.
RESULTS: Of the 7 women who had undergone a radical hysterectomy during pregnancy, 4 had a cesarean radical hysterectomy at a mean gestational age of 35.4 weeks (range, 32.3-38 weeks) and 3 had a radical hysterectomy with a previable fetus in situ at a mean gestational age of 14.2 weeks. Demographics were similar between groups. Transfusion rates were significantly higher among pregnant women (57%) as compared to nonpregnant controls (9%) (p = 0.0009). The overall incidence of operative complications was similar between the pregnant women (43%) and nonpregnant controls (40%) (p = NS).
CONCLUSION: Radical hysterectomy performed in pregnant women was associated with higher blood loss and increased need for transfusion as compared to nonpregnant controls. No differences were observed in regards to other operative surgical complications between the two groups.

Entities:  

Mesh:

Year:  2013        PMID: 23947076

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  3 in total

1.  Cesarean radical hysterectomy for cervical cancer in the United States: a national study of surgical outcomes.

Authors:  Koji Matsuo; Rachel S Mandelbaum; Shinya Matsuzaki; Ernesto Licon; Lynda D Roman; Maximilian Klar; Brendan H Grubbs
Journal:  Am J Obstet Gynecol       Date:  2020-01-23       Impact factor: 8.661

2.  Neoadjuvant Chemotherapy in Pregnant Patients with Cervical Cancer: A Monocentric Retrospective Study.

Authors:  Federica Bernardini; Gabriella Ferrandina; Caterina Ricci; Anna Fagotti; Francesco Fanfani; Anna Franca Cavaliere; Benedetta Gui; Giovanni Scambia; Rosa De Vincenzo
Journal:  Curr Oncol       Date:  2022-08-14       Impact factor: 3.109

Review 3.  Gynecologic Malignancies in Pregnancy: Balancing Fetal Risks With Oncologic Safety.

Authors:  Christina N Cordeiro; Mary L Gemignani
Journal:  Obstet Gynecol Surv       Date:  2017-03       Impact factor: 2.347

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.